Epstein Secrets

izer-s-covid-vaccine-trial-plan-may-beat- rivals-to-early-look?smd=premium> (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot works before their fastest-moving rivals." The firms "plan a first look

partment, which said, "Due to increased attention and activity in anticipation of an announcement from Attorney General Daniel Cameron regarding the Breonna Taylor case, a decision was made to accelerate plans to physically restrict access to the downtown area." Reuters <https://www.reuters.com/article/

-covid- vaccine-trial-in-days?smd=premium> (11/11, Langreth, 4.73M) reports that the "same US explosion of Covid-19 EFTA00137117 cases that helped Pfizer Inc. get results for its vaccine trial earlier this week is helping speed along Moderna's trial." Moderna "said Wednesday its study has accumulated more

ng outcomes are good news for Moderna, too." Politico <https://www.politico.com/news/2020/11/11/modema-to-reveal-covid-vaccine- data-436113> (11/11, Brennan, 4.29M) reports Fauci "told a Financial Times conference on Wednesday that the Moderna data would be coming in the `next few days to a week' and tha

e Trial Ready To Analyze Shot's Effectiveness. Bloomberg (11/11, Langreth, 4.73M) reports that the "same US explosion of Covid-19 cases that helped Pfizer Inc. get results for its vaccine trial earlier this week is helping speed along Moderna's trial." Moderna "said Wednesday its study has accumulated more

messenger RNA for their vaccines," and NIAID Director Fauci "has said Pfizer's promising outcomes are good news for Moderna, too." Politico (11/11, Brennan, 4.29M) reports Fauci "told a Financial Times conference on Wednesday that the Moderna data would be coming in the 'next few days to a week' and tha

n people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot works before their fastest-moving rivals." The firms "plan a first loo

joined the American Civil Liberties Union and the Brennan Center for Justice in asking a state appellate c

n people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot works before their fastest-moving rivals." The firms "plan a first loo

joined the American Civil Liberties Union and the Brennan Center for Justice in asking a state appellate c

e Trial Ready To Analyze Shot's Effectiveness. Bloomberg (11/11, Langreth, 4.73M) reports that the "same US explosion of Covid-19 cases that helped Pfizer Inc. get results for its vaccine trial earlier this week is helping speed along Moderna's trial." Moderna "said Wednesday its study has accumulated more

messenger RNA for their vaccines," and NIAID Director Fauci "has said Pfizer's promising outcomes are good news for Moderna, too." Politico (11/11, Brennan, 4.29M) reports Fauci "told a Financial Times conference on Wednesday that the Moderna data would be coming in the 'next few days to a week' and tha